Chick Chorioallantoic Membrane Model and Precision Cancer Therapy

Status

Published

on 29 Dec 2019

Year of Creation

2019

Elsevier Inc

Registration Number

TX0008945734

on 29 Dec 2019

The U.S. Copyright record (Registration Number: TX0008945734) dated 29 Dec 2019, pertains to an electronic file (eService) titled "Chick Chorioallantoic Membrane Model and Precision Cancer Therapy" created in 2019. The copyright holder is Elsevier Inc, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Elsevier Inc.

Elsevier Inc

Application Details

Registration Number

TX0008945734

Registration Date

12/29/2019

Year of Creation

2019

Agency Marc Code

DLC-CO

Record Status

New

Physical Description

Book

First Publication Nation

United States

ISBN

9780128173985

Preexisting Material

permissioned materials

Personal Authors

Fuyuhiko Tamanoi

Corporate Authors

Elsevier Inc

Notes

Rights Note: permissions@elsevier.com

Local Copyright Note: C.O. correspondence

Material Matter Claimed Note: text, compilation of contributions

Statements

Application Title Statement: Chick Chorioallantoic Membrane Model and Precision Cancer Therapy

Author Statement: Fuyuhiko Tamanoi Domicile: United States Citizenship: United States Authorship: text, compilation of contributions

Notes

Rights Note: permissions@elsevier.com

Local Copyright Note: C.O. correspondence

Material Matter Claimed Note: text, compilation of contributions

Statements

Application Title Statement: Chick Chorioallantoic Membrane Model and Precision Cancer Therapy

Author Statement: Fuyuhiko Tamanoi Domicile: United States Citizenship: United States Authorship: text, compilation of contributions

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.